Correlation between Lethal Toxin-Neutralizing Antibody Titers and Protection from Intranasal Challenge with Bacillus anthracis Ames Strain Spores in Mice after Transcutaneous Immunization with Recombinant Anthrax Protective Antigen

@article{Peachman2006CorrelationBL,
  title={Correlation between Lethal Toxin-Neutralizing Antibody Titers and Protection from Intranasal Challenge with Bacillus anthracis Ames Strain Spores in Mice after Transcutaneous Immunization with Recombinant Anthrax Protective Antigen},
  author={K. Peachman and M. Rao and C. Alving and R. Burge and S. Leppla and V. Rao and G. Matyas},
  journal={Infection and Immunity},
  year={2006},
  volume={74},
  pages={794 - 797}
}
ABSTRACT Transcutaneous immunization of mice with recombinant protective antigen (rPA) of Bacillus anthracis resulted in significantly higher lethal toxin-neutralizing antibody titers than did intramuscular injection of alum-adsorbed rPA. Immunized mice were partially protected against intranasal challenge with 235,000 (10 50% lethal doses) Ames strain B. anthracis spores. A highly significant correlation was observed between toxin-neutralizing antibody titer and survival after challenge… Expand
Protection against anthrax and plague by a combined vaccine in mice and rabbits.
TLDR
Data show that the protective efficacy was unaffected when the antigens were administered in combination, and that immunized rF1 + rV and rPA antigen together was as effective as separately for induction of serological antibody response, and these titers were maintained for over 1 year in mice. Expand
Anthrax Vaccine Antigen-Adjuvant Formulations Completely Protect New Zealand White Rabbits against Challenge with Bacillus anthracis Ames Strain Spores
  • K. Peachman, Qin Li, +6 authors Mangala Rao
  • Medicine, Biology
  • Clinical and Vaccine Immunology
  • 2011
TLDR
The needle-free skin delivery and liposomal formulation that were found to be effective in two different animal model systems appear to be promising candidates for next-generation anthrax vaccine development. Expand
Immunization of Mice with Anthrax Protective Antigen Limits Cardiotoxicity but Not Hepatotoxicity Following Lethal Toxin Challenge
TLDR
It was apparent that neither vaccine modality prevented hepatic intoxication, despite high Ab titers and ultimate survival of the subject, and it is proposed that organ-specific intoxication should be monitored routinely during research into new vaccine modalities. Expand
Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine
  • W. Keitel
  • Medicine
  • Expert review of vaccines
  • 2006
TLDR
Clinical trials of one of the most promising vaccine candidates, recombinant protective antigen (rPA)102, suggest that rPA102 is well tollerated and immunogenic, and further trials are necessary to identify optimal formulations and immunization regimens for pre- and postexposure prophylaxis. Expand
Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine
TLDR
It is demonstrated that CIA06B is capable of providing long-term immunity when used as an adjuvant in a PA-based anthrax vaccine. Expand
Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.
TLDR
Under the conditions tested in the rabbit animal model, significantly higher serological responses were observed in rabbits that had been injected with rPA formulated with aluminum hydroxide gel adjuvant and formaldehyde, however, differences in short-term efficacy were not observed. Expand
Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
TLDR
By facilitating more efficient phagocytic clearance of spores, antibodies against individual exosporium components can contribute to protection against B. anthracis infection. Expand
Development of a multiple-antigen protein fusion vaccine candidate that confers protection against Bacillus anthracis and Yersinia pestis
TLDR
MaF2 is a promising multi-antigen vaccine candidate against anthrax and plague that warrants further investigation. Expand
In Vitro and In Vivo Characterization of Anthrax Anti-Protective Antigen and Anti-Lethal Factor Monoclonal Antibodies after Passive Transfer in a Mouse Lethal Toxin Challenge Model To Define Correlates of Immunity
TLDR
Serum collected 24 h after passive transfer had LeTx-neutralizing activity when tested using a standard LeTx neutralization assay, but neutralization titers measured using this assay did not correlate with protection against LeTx challenge, prompting the suggestion that this LeTxneutralization assay may be a more biologically relevant Neutralization assay to predict the in vivo protective capacity of Letx- neutralizing antibodies. Expand
Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits.
TLDR
The key domains of protective antigen and lethal factor that may be critical for inducing protective immunity are combined into one recombinant molecule that conferred 100% protection in rabbits challenged intranasally with a 100 LD(50) dose of Bacillus anthracis Ames strain spores. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 13 REFERENCES
Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.
TLDR
Results suggested that the antibody response, as determined by the quantitative anti-rPA IgG ELISA and toxin neutralizing antibody (TNA) assay, were significant predictors of protection against a B. anthracis aerosol spore challenge in rabbits. Expand
Induction of protective immunity against lethal anthrax challenge with a patch.
TLDR
A formulated, pressure-sensitive, dry adhesive patch, which is stable and can be manufactured in large scale, elicited comparable immunoglobulin G and TNA responses, suggesting that an anthrax vaccine patch is feasible and should advance into clinical evaluation. Expand
Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals
TLDR
The data demonstrate that the recombinant baculovirus- and vaccinia virus-produced PAs were immunogenic in both guinea pigs and mice, that the b Baculov virus-PA recombinant was a useful source of immunogenic PA, and thatvaccinia virus -PA recombinants may be feasible live anthrax vaccine candidates worthy of consideration for further development as live vaccines. Expand
Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants
TLDR
Statistical analysis of survival data in the guinea pigs indicated that PA-MPL-CWS and PA- MPL-TDM-C WS were more efficacious than the currently licensed human anthrax vaccine. Expand
Needle-Free Skin Patch Vaccination Method for Anthrax
TLDR
Three immunizations of mice with recombinant protective antigen by transcutaneous immunization induced long-term neutralizing antibody titers that were superior to those obtained with aluminum-adsorbed rPA, and 100% protection was observed against lethal anthrax challenge. Expand
Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.
TLDR
It is demonstrated, for the first time, that cutaneous or nasal mucosal administration of rPA provides complete protection against inhalational anthrax in rabbits. Expand
Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages
TLDR
An overlooked population of anti-PA MAbs are described for the first time that function to increase the potency of LeTx against murine macrophage cell lines and support a possible mechanism of enhancement. Expand
Differences in susceptibility of inbred mice to Bacillus anthracis.
TLDR
The mouse model appears to be useful in studies on host resistance to anthrax and on the pathogenesis of the infection, especially when studies suggested that resistance to the Sterne strain is determined by a single dominant gene or gene complex. Expand
Validation of the anthrax lethal toxin neutralization assay.
TLDR
This in vitro assay measures the functional ability of antisera, containing antibodies to anthrax lethal toxin, to specifically protect J774A.1 cells against Bacillus anthracis lethal toxin cytotoxicity. Expand
Murine Model of Pulmonary Anthrax: Kinetics of Dissemination, Histopathology, and Mouse Strain Susceptibility
TLDR
The characteristics of host and Bacillus anthracis interactions in a murine pulmonary-infection model are described to investigate the importance of specific bacterial genes in virulence, to identify components of the host immune system that are important in providing innate and acquired protection, and for testing diagnostic and therapeutic strategies. Expand
...
1
2
...